People · Operator
Named in public records as an officer, director or promoter · active 2013–2025 · Biotechnology, Energy / Climate, Consumer / Retail
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| GT Biopharma, Inc. | — | Biotechnology | Series B | $53.5M | $98.3M | 2025 |
| Growing Energy Labs, Inc. | — | Energy / Climate | Series A | $20.3M | $3.7M | 2013 |
| Wizard Brands, Inc. | — | Consumer / Retail | Series A | $9.4M | $23.2M | 2019 |
Michael Breen at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Michael Breen on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Milo Werner | 1 | 7 |
| Michael Mathews | 1 | 5 |
| Charles Casamento | 1 | 5 |
| John Scull | 1 | 5 |
| Ben Brown | 1 | 3 |
| Andrew Ritter | 1 | 3 |
| Vadim Mats | 1 | 3 |
| Miguel Granier | 1 | 3 |
| David Saloff | 1 | 2 |
| Anthony Cataldo | 1 | 2 |
| Paul Kessler | 1 | 2 |
| Steven Weldon | 1 | 2 |
| James Lyons | 1 | 2 |
| Paul L Kessler | 1 | 2 |
| Michael D. Breen | 1 | 2 |
| Bruce Wendel | 1 | 2 |
| Greg Suess | 1 | 1 |
| John Macaluso | 1 | 1 |
| John Maatta | 1 | 1 |
| Ryan Wartena | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.